Zhang Li, Liu Fang, Xue Jessica, Lee Seul A, Liu Lu, Riordan Stephen M
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Faculty of Medicine, Monash University, Melbourne, VIC, Australia.
Front Microbiol. 2022 Feb 24;13:801892. doi: 10.3389/fmicb.2022.801892. eCollection 2022.
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract with unknown etiology. The pathogenesis of IBD results from immune responses to microbes in the gastrointestinal tract. Various bacterial species that are associated with human IBD have been identified. However, the microbes that trigger the development of human IBD are still not clear. Here we review bacterial species that are associated with human IBD and their pathogenic mechanisms to provide an updated broad understanding of this research field. IBD is an inflammatory syndrome rather than a single disease. We propose a three-stage pathogenesis model to illustrate the roles of different IBD-associated bacterial species and gut commensal bacteria in the development of human IBD. Finally, we recommend microbe-targeted therapeutic strategies based on the three-stage pathogenesis model.
炎症性肠病(IBD)是一种病因不明的胃肠道慢性炎症性疾病。IBD的发病机制源于对胃肠道微生物的免疫反应。已经鉴定出多种与人类IBD相关的细菌种类。然而,引发人类IBD发展的微生物仍不明确。在此,我们综述与人类IBD相关的细菌种类及其致病机制,以对该研究领域提供最新的全面理解。IBD是一种炎症综合征而非单一疾病。我们提出一个三阶段发病机制模型,以阐明不同IBD相关细菌种类和肠道共生菌在人类IBD发展中的作用。最后,我们基于三阶段发病机制模型推荐针对微生物的治疗策略。